Advertisement

U.S. markets open in 1 hour 24 minutes

S&P Futures
4,169.25
+22.50(+0.54%)
Dow Futures
32,903.00
+146.00(+0.45%)
Nasdaq Futures
13,320.25
+91.50(+0.69%)
Russell 2000 Futures
1,932.80
+11.00(+0.57%)
Crude Oil
88.20
-0.81(-0.91%)
Gold
1,798.50
+7.30(+0.41%)

Advertisement

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

3.9100

+0.2800

(+7.71%)

At close: 04:00PM EDT

3.9500

+0.04

(+1.02%)

Pre-Market:

07:00AM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	3.6300
Open	3.5000
Bid	0.0000 x 1200
Ask	3.9600 x 3000
Day's Range	3.5000 - 3.9800
52 Week Range	0.4600 - 4.0900
Volume	287,676
Avg. Volume	1,449,100

Market Cap	151.261M
Beta (5Y Monthly)	0.21
PE Ratio (TTM)	N/A
EPS (TTM)	-1.2810
Earnings Date	Aug 11, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	10.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TRVI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Trevi Therapeutics, Inc.
Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Rating
Fair Value
Economic Moat
7 days agoMorningstar

All

PR Newswire
Trevi Therapeutics to Report Q2 2022 Financial Results and Provide a Corporate Update on August 11, 2022
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of prurigo nodularis and chronic cough in adults with idiopathic pulmonary fibrosis (IPF), today announced that management will host a conference call and live audio webcast on Thursday, August 11, 2022, at 4:30 p.m. ET, to provide a corporate update and review the Company's financial results for the second quarter ended June 30
- Fluence Energy, Inc. Announces Third Quarter Earnings Release Date, Conference Call and Webcast
  GlobeNewswire
- NXT Energy Solutions Announces Release Date for Its Second Quarter 2022 Results and Conference Call
  GlobeNewswire
InvestorPlace
5 Penny Stocks to Buy on the Dip
Many investors are currently fearful of the stock market downtrend and aren’t as active in the market. Moreover, the risk of a recession has also discouraged any investments in the stock market. However, penny stocks with excellent growth prospects offer a unique opportunity for long-term profits, especially in the current dip. 7 Best AI Stocks to Buy Now Nonetheless, penny stocks can be risky in the short term due to their low market capitalization and trading volume. However, companies with so
Simply Wall St.
Is Trevi Therapeutics, Inc.'s (NASDAQ:TRVI) Shareholder Ownership Skewed Towards Insiders?
If you want to know who really controls Trevi Therapeutics, Inc. ( NASDAQ:TRVI ), then you'll have to look at the...